VC Profile: Jeito Capital in final stretch of biotech fund deployment


Rafaèle Tordjman, Jeito Capital

At a time when many big-ticket GPs are buying up specialist life science investors, France-based Jeito Capital is focused on staying an independent investor as it gears up to deploy the remaining third of its EUR 534m debut fund, founder Rafaèle Tordjman tells Unquote.



Source link

Leave a Reply

Your email address will not be published.